Blockbid

Blockbid

ICO Ended
14,744 Views
Blockbid is an ultra-secure exchange with the goal of facilitating the highest volume of trades for the most cryptocurrencies with a single login. Trade all of the top coins on one exchange. Ease of access - catering to new and experienced traders. Security from the ground up. Operating in accordance with AML/CTF Act. Lowest transaction fees to reduce the cost of trading.
8.3
TOTAL SCORE
7.7
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 22 Oct 2017 - 20 Nov 2017
Country: Australia
Token info
Ticker: BID
Platform: Ethereum
Available for sale: 30,000,000 BID (80%)
Financial
Raised $ 1,200,000
ICO Price: 1.23 USD
Accepting: ETH
Soft cap: 1,000,000 BID
Hard cap: 3,000,000 BID
ICO (October)
Blockbid is an ERC20 compliant token based on the Ethereum blockchain. Blockbid smart contract and tokens will launch on 22nd of October 2017
EARLY ACCESS Q4 2017
Beta testing and product refinement stage. Early access members will receive 0% transaction fee as a reward for joining. To sign-up for early access, subscribe on the Blockbid website
PUBLIC LAUNCH Q1 2018
Ultra-secure platform running on Australia’s fastest exchange network to facilitate up to 1 million transactions per second, with security built from the ground up. Fully compliant with Australian AML/CTF Ac
FIAT TRADING Q3 2018
Blockbid will support trading of a wide range of mainstream fiat currencies for ease of access
MOBILE EXCHANGE Q4 2018
Launch Blockbid app as a mobile exchange platform with personal private key wallet
Screenshots taken on 3 Feb 2018
Ben Sapper
CEO
Participates in a number of projects
Gabriel Govinda
Director
Participates in a number of projects
Matt Youill
CSO
Participates in a number of projects
Toby Tremayne
CTO
Participates in a number of projects
Emma Hoffman
CMO
Participates in a number of projects
Bernard Peh
Blockchain Technologist
Participates in a number of projects
Rudi Yardley
Senior Front End Developer
Participates in a number of projects
Chris Demaria
Network Security Engineer
Participates in a number of projects
Daniel Mechea
Data Scientist
Participates in a number of projects
Hunain Aslam
UI Developer
Participates in a number of projects

Advisors (1)

Jeremy Kinstlinger
Brokerage Specialist
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Fan360
The first sports community for fans, that covers the complete fan experience. Follow your favourite sports star, club or brand and get rewarded for engaging.
Upcoming
DATA
DATA is a blockchain project initiated and governed by Blockchain Data Foundation Limited ("Blockchain Data Foundation", or BDF from hereafter), a company limited by guarantee to be incorporated in Singapore and governed in a not-for-profit manner. This project is being developed in collaboration with Yomob International Co., Ltd. ("Yomob"), a mobile monetization-as-a-service company.
Upcoming
REPU
The REPU system (abbreviated from English – "reputation") is a revolutionary project that allows you to completely rethink the way social networks are perceived. REPU is a rating and feedback system based on decentralized blockchain technology. Technology allows you to completely replace the system of “likes” with the rating - both for users and for companies. The rating, subsequently, can be used as an assessment tool in various areas of the individual’s life - starting with professional skills, financial stability, and ending with all possible aspects of behavior and interaction with the public.
Upcoming
Quantler
Quantler is a blockchain for creating, analysing, sharing and running of decentralized structured investment products. Create structured products (such as an ETF) in equities or cryptocurrencies using themes. As there are a lot of the tokenized products being launched (currently over 1 900 available) the structured products for these assets are lacking behind (such as sector-based ETFs). Using Quantler’s blockchain anyone can create structured products (for regular assets such as Equities and cryptocurrencies) and run them on a decentralized network (much like smart contracts). Quantler also allows for regular assets, for this market Quantler’s solution is more flexible and has a lower costs base (targeted for exchanges, family offices and investment managers). The QUANT token’s intrinsic value is dependent on the AUM (asset under management) by the entire network. Quantler is like a Vanguard or BlackRock, but then in the form of a network.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.